ESTAZOLAM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for estazolam and what is the scope of freedom to operate?
Estazolam
is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Sa, Novitium Pharma, Watson Labs, and Abbott, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for estazolam. Four suppliers are listed for this compound.
Summary for ESTAZOLAM
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Clinical Trials: | 5 |
Patent Applications: | 6,107 |
Drug Prices: | Drug price trends for ESTAZOLAM |
What excipients (inactive ingredients) are in ESTAZOLAM? | ESTAZOLAM excipients list |
DailyMed Link: | ESTAZOLAM at DailyMed |
Recent Clinical Trials for ESTAZOLAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The First Affiliated Hospital with Nanjing Medical University | N/A |
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Phase 4 |
Haitao Tu | Phase 4 |
Pharmacology for ESTAZOLAM
Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for ESTAZOLAM
Anatomical Therapeutic Chemical (ATC) Classes for ESTAZOLAM
US Patents and Regulatory Information for ESTAZOLAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novitium Pharma | ESTAZOLAM | estazolam | TABLET;ORAL | 074826-002 | Jul 3, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | ESTAZOLAM | estazolam | TABLET;ORAL | 074818-002 | Aug 19, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Dr Reddys Labs Sa | ESTAZOLAM | estazolam | TABLET;ORAL | 074921-002 | Jul 10, 1997 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novitium Pharma | ESTAZOLAM | estazolam | TABLET;ORAL | 074826-001 | Jul 3, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Dr Reddys Labs Sa | ESTAZOLAM | estazolam | TABLET;ORAL | 074921-001 | Jul 10, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbott | PROSOM | estazolam | TABLET;ORAL | 019080-001 | Dec 26, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ESTAZOLAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | PROSOM | estazolam | TABLET;ORAL | 019080-001 | Dec 26, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | PROSOM | estazolam | TABLET;ORAL | 019080-002 | Dec 26, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.